PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How are ADHD clinical trial participants assigned to a treatment?

ANSWER

As with all clinical trials, ADHD clinical trial participants are randomly assigned  to either get the new treatment or the current standard treatment, or a placebo.  Randomization helps to avoid bias in the study.

SOURCES:

ClinicalTrials.gov: "Open Studies | 'Attention Deficit Disorder with Hyperactivity."

Clinical Trials.gov: "About Clinical Studies."

Reviewed by Smitha Bhandari on January 17, 2017

SOURCES:

ClinicalTrials.gov: "Open Studies | 'Attention Deficit Disorder with Hyperactivity."

Clinical Trials.gov: "About Clinical Studies."

Reviewed by Smitha Bhandari on January 17, 2017

NEXT QUESTION:

If there is no standard treatment, how do clinical trials for ADHD compare new treatments?

WAS THIS ANSWER HELPFUL

"ALEXA, ASK WEBMD"

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.